Incyte Corporation - Common Stock (NQ:INCY)

117.14 -4.21 (-3.47%)

Delayed Quote Updated: 4:00 PM EDT, Oct 1, 2026 Add to My Watchlist

Price and Volume

Volume	2,364,880
Open	120.47
Bid (Size)	116.46 (100)
Ask (Size)	119.18 (100)
Prev. Close	121.35
Today's Range	117.00 - 121.22
52wk Range	82.81 - 132.60
Shares Outstanding	222,430,635
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Q2 Earnings Roundup: Incyte (NASDAQ:INCY) And The Rest Of The Biotechnology Segment

September 30, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how biotechnology stocks f...

Via StockStory

Incyte (NASDAQ:INCY) Combines High Growth Momentum With a Breakout Setup ↗

September 30, 2026

Via Chartmill

Performance

YTD	+15.5%	+15.5%
1 Month	-4.9%	-4.9%
3 Month	+2.9%	+2.9%
6 Month	+24.2%	+24.2%
1 Year	+38.1%	+38.1%

More News

Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva

September 25, 2026

From Mirum Pharmaceuticals, Inc. and Incyte

Via Business Wire

Discover the top S&P500 movers in Tuesday's pre-market session. ↗

September 22, 2026

Via Chartmill

Incyte Data at the European Academy of Dermatology and Venereology (EADV) Congress Underscore the Breadth of Incyte’s Inflammation and Autoimmunity Portfolio

September 22, 2026

From Incyte

Via Business Wire

Incyte (NASDAQ:INCY) Combines Minervini Trend Template Strength With High-Growth Momentum ↗

September 18, 2026

Via Chartmill

Incyte (NASDAQ:INCY) Combines High Growth Momentum with a Breakout Setup ↗

September 08, 2026

Via Chartmill

Incyte (NASDAQ:INCY) Passes Minervini Trend and High-Growth Screens, But Setup Demands Patience ↗

August 27, 2026

Via Chartmill

Incyte Maps Post-JAKAFI Growth With Pipeline Push and $4B Sales Target ↗

September 19, 2026

Via MarketBeat

3 Growth Stocks to Add to Your Roster

September 17, 2026

Via StockStory

1 Cash-Heavy Stock for Long-Term Investors and 2 We Ignore

September 16, 2026

Via StockStory

Incyte (INCY): 3 Reasons We Love This Stock

September 14, 2026

Via StockStory

Incyte (NASDAQ:INCY) Combines High Growth Momentum with a Breakout Setup ↗

August 17, 2026

Via Chartmill

Here's How Much $1000 Invested In Incyte 20 Years Ago Would Be Worth Today ↗

September 11, 2026

Via Benzinga

2 Cash-Producing Stocks with Promising Prospects and 1 We Brush Off

September 11, 2026

Via StockStory

3 Market-Beating Stocks with Competitive Advantages

September 09, 2026

Via StockStory

2 Profitable Stocks with Impressive Fundamentals and 1 We Brush Off

September 04, 2026

Via StockStory

Incyte to Present at Upcoming Investor Conferences

September 01, 2026

From Incyte

Via Business Wire

Here’s How Much You Would Have Made Owning Incyte Stock In The Last 20 Years ↗

August 20, 2026

Via Benzinga

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 07, 2026

From Incyte Corporation

Via Business Wire

July 31, 2026

Via StockStory

Opzelura® (ruxolitinib) Cream Becomes First Steroid-Free Topical JAK Inhibitor Approved in the European Union for Adults with Moderate Atopic Dermatitis

July 29, 2026

From Incyte

Via Business Wire

Exploring the top movers within the S&P500 index during today's session. ↗

July 28, 2026

Via Chartmill

Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below. ↗

July 28, 2026

Via Chartmill

Incyte Q2 Earnings Call Highlights ↗

July 28, 2026

Via MarketBeat

Frequently Asked Questions

Is Incyte Corporation - Common Stock publicly traded?

Yes, Incyte Corporation - Common Stock is publicly traded.

What exchange does Incyte Corporation - Common Stock trade on?

Incyte Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Incyte Corporation - Common Stock?

The ticker symbol for Incyte Corporation - Common Stock is INCY on the Nasdaq Stock Market

What is the current price of Incyte Corporation - Common Stock?

The current price of Incyte Corporation - Common Stock is 117.14

When was Incyte Corporation - Common Stock last traded?

The last trade of Incyte Corporation - Common Stock was at 10/01/26 04:00 PM ET

What is the market capitalization of Incyte Corporation - Common Stock?

The market capitalization of Incyte Corporation - Common Stock is 26.06B

How many shares of Incyte Corporation - Common Stock are outstanding?

Incyte Corporation - Common Stock has 26B shares outstanding.